When Joseph Heisler was diagnosed with von Hippel-Lindau disease 30 years ago, there was hardly any information on the condition. Fast forward three decades, there is an FDA-approved drug and a ...
FDA approval of breakthrough treatment brings welcome hope. BOSTON, Aug. 18, 2021 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved the first-ever pharmaceutical treatment for ...
Researchers at the Francis Crick Institute have mapped all the possible outcomes of changes to a tumor-suppressing gene called VHL, the first step in a huge research endeavor to unpick the outcomes of ...
A decade ago this past June, my sister died at the National Institutes of Health. I still have faith in them, and I hope that the country does, too. When she was 10 years old, floaters appeared in ...
Von Hippel-Lindau disease (VHL), also called VHL syndrome, is a rare genetic disorder that causes tumors and cysts to form throughout your body. VHL disease can be found all over the world across all ...
Merck & Co., Inc. MRK announced that the FDA has granted approval to its novel HIF-2α inhibitor belzutifan (120 mg once daily) to treat some von Hippel-Lindau (VHL) disease-associated tumors. The drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results